Xellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
01 7Xellia Pharmaceuticals
02 5Dr. Reddy's Laboratories
03 1ANFARM HELLAS S.A.
04 21Accord healthcare
05 2Aspiro Pharma
06 1Aurobindo Pharma Limited
07 5Baxter Healthcare Corporation
08 1Bayer AG
09 2Be Pharma B.V.
10 1Biocon
11 4Biological E
12 4CUBIST PHARMS INC
13 2Cipla
14 1Clinigen Group
15 2Deva Holding AS
16 1Dr Reddy's Laboratories (Pty) Ltd
17 2Eugia Pharma
18 1Fosun Pharmaceutical
19 2Fresenius Kabi USA
20 3Hainan Poly Pharm
21 4Hameln Pharma GmbH
22 1Hangzhou Zhongmei Huadong Pharmaceutical
23 2Health Biotech
24 7Hikma Pharmaceuticals
25 4Hospira, Inc.
26 2Jiangsu Hengrui Medicine
27 1Juno Pharmaceuticals Pty Ltd
28 1Kaliberr Labs
29 2LABORATORIOS NORMON SA
30 2Labatec Pharm
31 2Lorien Laboratories Sl
32 4MIP Pharma
33 2MSD Pharmaceuticals
34 1Macleods Pharmaceuticals Limited
35 2Maia Pharmaceuticals
36 2Meitheal Pharmaceuticals
37 2Melita Pharm, S.L.
38 13Merck & Co
39 2Norameda
40 4Noridem Enterprises Limited
41 2Noridem Enterprises Ltd
42 2Olon S.p.A
43 6Pfizer Inc
44 1Pharma Dynamics
45 1Qilu Pharmaceutical
46 2Reddy Pharma Iberia S.A.
47 2Reig Jofre
48 2Sagent Pharmaceuticals
49 1Sandoz B2B
50 2Tarbis Farma Sl
51 1Teva Pharmaceutical Industries
52 2Tillomed Laboratories Ltd
53 2Viatris
54 2Vocate Pharmaceuticals S.A
55 2Zentiva
56 1Zhejiang Hisun Pharmaceutical
01 2 Powder for Solution (Lyophilized Powder)
02 1Daptomycin 350Mg 1 Unit Parenteral Use
03 1Daptomycin 500Mg 10Ml 1 Units Parenteral Use
04 5INF
05 1INJ
06 2Injectable
07 4Injection
08 45Injection/Infusion Solution
09 2Lyophilizate
10 2Lyophilized Injection
11 1POI
12 3POWDER FOR SOLUTION
13 38POWDER;INTRAVENOUS
14 23Powder For Injection And Infusion Solution
15 17Powder For Solution For Injection And Infusion
16 4SOLUTION;INTRAVENOUS
17 4Solution For Injection
18 4Vial
01 6Allowed
02 19Approved
03 7Authorised
04 28Authorized
05 1Available Dossier- US-EU-RoW
06 2Cancelled
07 9DISCN
08 10Generic
09 2Marketed
10 2Not Marketed
11 1Originator
12 3PRESCRIPTION
13 20Prescription
14 32RX
15 2Suspended
16 1Withdrawn
17 14Blank
01 1CUBACT
02 2CUBICIN
03 2CUBICIN RF
04 15Cubicin
05 1Cusyn
06 1DABUCOR 500
07 34DAPTOMYCIN
08 2DAPTOMYCIN FOR INJECTION
09 4DAPTOMYCIN IN 0.9% SODIUM CHLORIDE
10 1DAPZURA RT
11 1Dapicub
12 2Daptomicina Accord
13 2Daptomicina Accordpharma
14 1Daptomicina Baxter
15 2Daptomicina Cipla
16 1Daptomicina Fosun Pharma
17 2Daptomicina Hikma
18 2Daptomicina Lorien
19 2Daptomicina Normon
20 2Daptomicina Tarbis
21 2Daptomicina Tillomed
22 2Daptomicina Xellia
23 2Daptomycin
24 2Daptomycin Accord
25 4Daptomycin Accord Healthcare
26 4Daptomycin Accordpharma
27 1Daptomycin Anfarm
28 2Daptomycin Be Pharma
29 2Daptomycin Dr. Reddys
30 1Daptomycin Equity
31 2Daptomycin Eugia
32 1Daptomycin Hameln
33 2Daptomycin Hikma
34 4Daptomycin Hospira
35 2Daptomycin Labatec
36 2Daptomycin Melita Pharm
37 2Daptomycin Mip
38 2Daptomycin Norameda
39 4Daptomycin Noridem
40 2Daptomycin Sala
41 2Daptomycin Zentiva
42 2Daptomycin "Accord Healthcare"
43 2Daptomycin "Accordpharma"
44 2Daptomycin "Hameln"
45 2Daptomycin "Hospira"
46 2Daptomycin "Mip"
47 2Daptomycin "Noridem"
48 1Daptomycin hameln
49 1Drymred 500
50 2Xelltempra
51 2Zepraxen
52 14Blank
01 3Canada
02 3China
03 16Denmark
04 6Estonia
05 7India
06 4Italy
07 8Malta
08 4Norway
09 7South Africa
10 32Spain
11 19Sweden
12 6Switzerland
13 2Turkey
14 42USA
Xellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2016-06-15
Application Number : 206005
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2019-05-01
Application Number : 208375
Regulatory Info : RX
Registration Country : USA
Xellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
Regulatory Info : Generic
Registration Country : Denmark
Brand Name :
Dosage Form : Lyophilized Injection
Dosage Strength : 300MG/Vial
Packaging : 1 vial/pack
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Denmark
Xellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
Regulatory Info : Generic
Registration Country : Denmark
Brand Name :
Dosage Form : Lyophilized Injection
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Denmark
Xellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Daptomicina Xellia
Dosage Form : Powder For Injection And Infusion Solution
Dosage Strength : 350MG
Packaging :
Approval Date : 28-12-2018
Application Number : 82669
Regulatory Info : Authorized
Registration Country : Spain
Xellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Daptomicina Xellia
Dosage Form : Powder For Injection And Infusion Solution
Dosage Strength : 500MG
Packaging :
Approval Date : 26-12-2018
Application Number : 82670
Regulatory Info : Authorized
Registration Country : Spain
Xellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Xelltempra
Dosage Form : Injection/Infusion Solution
Dosage Strength : 350mg
Packaging :
Approval Date : 21-10-2025
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
Xellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Xelltempra
Dosage Form : Injection/Infusion Solution
Dosage Strength : 500mg
Packaging :
Approval Date : 21-10-2025
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 350MG/VIAL
Packaging :
Approval Date : 2020-08-31
Application Number : 211403
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Daptomycin
Dosage Form : Injectable
Dosage Strength : 350 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Daptomycin
Dosage Form : Injectable
Dosage Strength : 500 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : PRESCRIPTION
Registration Country : Canada
Brand Name : DAPTOMYCIN FOR INJECTION
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date :
Application Number : 2490463
Regulatory Info : PRESCRIPTION
Registration Country : Canada
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CUBICIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2003-09-12
Application Number : 21572
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CUBICIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2003-09-12
Application Number : 21572
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CUBICIN RF
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2016-07-06
Application Number : 21572
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2018-04-11
Application Number : 206077
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2014-09-12
Application Number : 202857
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 350MG/VIAL
Packaging :
Approval Date :
Application Number : 203797
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2016-03-25
Application Number : 91039
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2018-06-05
Application Number : 205037
Regulatory Info : RX
Registration Country : USA
